Records from the PA Dept. of Human Services shows thirteen children aged 0 to 5 years old were given ECT in 2014 alone.
A recent study published in Evidence Based Mental Health warns against the dangers of long term treatment with electroconvulsive therapy (or ECT) and warns that cognitive impairments associated with ECT may cause significant cognitive side effects in patients treated long-term.
Despite its claim to virtue as a government regulatory agency whose mission is to protect the public, in truth the Food and Drug Administration (FDA) all too often functions as an industry ally—and the agency’s history and current avoidance of responsibility with electroshock (also known as ECT) is an egregious example.
A recent study was published in Progress in Neurology and Psychiatry by consultant psychiatrist Latha Guruvaiah and colleagues. It recorded patients’ and their caregivers’ experiences and attitudes toward ECT following their treatment. However, it is no more than a patient satisfaction survey at one institution and adds nothing to the debate about the safety and effectiveness of ECT, except to confirm, once again, that ECT causes headaches, confusion, and memory loss.